StockData
DexCom Inc logo

DexCom Inc (DXCM) stock

DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3031% below fair value
$82.04+0.43 (+0.53%)

Close on Nov 17, 2026Market cap $30.60BP/E 32.3Yield –

DexCom price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

DexCom's price to sales ratio was 6.1× on Nov 11, 2026, against 5.5× a year earlier. Over the last 5 years it ranged from 4.9× to 22.4×, with a median of 11.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.1×+0.4
2025Dec 31, 20255.7×−2.0
2024Dec 31, 20247.7×−6.4
2023Dec 29, 202314.1×−1.6
2022Dec 30, 202215.7×−6.8
2021Dec 31, 202122.4×+2.9
2020Dec 31, 202019.5×+4.7
2019Dec 31, 201914.8×+3.2
2018Dec 31, 201811.6×+4.2
2017Dec 29, 20177.5×−2.0
2016Dec 30, 20169.5×−9.3
2015Dec 31, 201518.7×+0.2
2014Dec 31, 201418.6×+0.6
2013Dec 31, 201317.9×+7.4
2012Dec 31, 201210.6×+1.5
2011Dec 30, 20119.0×–

More DexCom figures

See a number that looks wrong?